Andrea Cox

Andrea Cox is currently a Professor of Medicine and Oncology at The Johns Hopkins University School of Medicine in Baltimore.  She earned her Ph.D. studying T cell immunology at The University of Virginia. She subsequently completed an M.D. and then Internal Medicine and Infectious Disease training at Johns Hopkins. As a member of the Viral Hepatitis Center in the Division of Infectious Diseases, she specializes in the treatment of patients with viruses that cause cancer, including hepatitis virus infections, and HIV. Her laboratory investigates human immune responses to SARS-CoV-2, hepatitis C virus (HCV), hepatitis B virus (HBV), and HIV, including mechanisms through which these viral infections stimulate and evade immune responses, and in vaccine development. She is the co-director of the Johns Hopkins SARS-CoV-2 Pathogenesis and Immunity Center. She was the principal investigator on the first prophylactic HCV vaccine trial ever implemented in an at-risk population, and is the lead immunologist on an ACTG trial of HBV vaccines in HIV infected patients.  She is dedicated to mentoring the next generation of physician scientists; directing the Johns Hopkins Medical Scientist Training Program since 2013, teaching immunology to medical and graduate students, and actively mentoring students and fellows.  She is a member of the American Society for Clinical Investigation and Alpha Omega Alpha Honor Society.